Artificial intelligence in the anterior segment of eye diseases
Author:
Corresponding Author:

Zhao-Hui Li and Zi Ye. 28 Fuxing Road, Haidian District, Beijing 100039, China. 13701239057@163.com; yeziclover@163.com

Affiliation:

Clc Number:

Fund Project:

Supported by National Natural Science Foundation of China (No.82101097; No.82070937).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Ophthalmology is a subject that highly depends on imaging examination. Artificial intelligence (AI) technology has great potential in medical imaging analysis, including image diagnosis, classification, grading, guiding treatment and evaluating prognosis. The combination of the two can realize mass screening of grass-roots eye health, making it possible to seek medical treatment in the mode of “first treatment at the grass-roots level, two-way referral, emergency and slow treatment, and linkage between the upper and lower levels”. On the basis of summarizing the AI technology carried out by scholars and their teams all over the world in the field of ophthalmology, quite a lot of studies have confirmed that machine learning can assist in diagnosis, grading, providing optimal treatment plans and evaluating prognosis in corneal and conjunctival diseases, ametropia, lens diseases, glaucoma, iris diseases, etc. This paper systematically shows the application and progress of AI technology in common anterior segment ocular diseases, the current limitations, and prospects for the future.

    Reference
    Related
    Cited by
Get Citation

Yao-Hong Liu, Lin-Yu Li, Si-Jia Liu, et al. Artificial intelligence in the anterior segment of eye diseases. Int J Ophthalmol, 2024,17(9):1743-1751

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:September 22,2023
  • Revised:March 25,2024
  • Adopted:
  • Online: August 20,2024
  • Published: